NEOGENOMICS LABORATORIES INC NPI 1073549663

NPI Details

NEOGENOMICS LABORATORIES INC is a clinical medical laboratory in Juno Beach, FL. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. NEOGENOMICS LABORATORIES INC NPI is 1073549663. The provider is registered as an organization entity type.

The provider's business location address is:

900 OCEAN DR APT 504
JUNO BEACH, FL
ZIP 33408-723
Phone: (866) 776-5907
Fax: (888) 443-4513

The provider's authorized official is Jeffrey Scott Sherman .
The authorized official title is Chief Financial Officer and has the following contact phone number (866) 776-5907.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure (HCPCS:88374)
• Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure (HCPCS:88374)
• Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Interpretation and report of genetic testing (HCPCS:88291)
• Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
• Flow cytometry technique for dna or cell analysis, 16 or more markers (HCPCS:88189)
• Microscopic genetic analysis of tumor, using computer-assisted technology (HCPCS:88361)
• Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
• Test for detecting genes associated with cancer (HCPCS:81455)
• Cell examination of urine, manual (HCPCS:88120)
• Microscopic genetic analysis of tumor, manual (HCPCS:88360)
• Microscopic genetic analysis of tumor, manual (HCPCS:88360)
• Preparation of tissue for examination by removing any calcium present (HCPCS:88311)
• Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure (HCPCS:88377)
• Test for detecting genes associated with blood related cancer (HCPCS:81450)
• Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
• Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
• Bone marrow, smear interpretation (HCPCS:85097)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure (HCPCS:88377)
• Genetic sequencing localization, initial procedure (HCPCS:88365)
• Genetic sequencing localization, each additional procedure (HCPCS:88364)
• Gene analysis (calreticulin), common variants (HCPCS:81219)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (v-raf murine sarcoma viral oncogene homolog b1) (HCPCS:81210)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10 (HCPCS:81339)
• Tissue culture for tumor disorders of bone marrow and blood cells (HCPCS:88237)
• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Gene analysis (myeloid differentiation primary response 88) for p.leu265pro variant (HCPCS:81305)
• Translocation analysis (bcr/abl1) major breakpoint (HCPCS:81206)
• Microscopic genetic analysis of tumor, using computer-assisted technology (HCPCS:88361)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Gene analysis (epidermal growth factor receptor), common variants (HCPCS:81235)
• Surgical pathology consultation and report on referred slides prepared elsewhere (HCPCS:88321)
• Preparation of tissue for examination by removing any calcium present (HCPCS:88311)
• Translocation analysis (bcr/abl1) minor breakpoint (HCPCS:81207)
• Gene rearrangement analysis (immunoglobulin heavy chain locus), variable region somatic mutation analysis (HCPCS:81263)
• Gene rearrangement analysis detection abnormal clonal population (t cell antigen receptor gamma) (HCPCS:81342)
• Gene rearrangement analysis (immunoglobulin kappa light chain locus) to detect abnormal clonal population (HCPCS:81264)
• Gene rearrangement analysis (immunoglobulin heavy chain locus) to detect abnormal clonal population amplified methodology (HCPCS:81261)
• Cell examination of urine, computer-assisted (HCPCS:88121)
• Surgical pathology consultation and report on referred material requiring preparation of slides (HCPCS:88323)
• Gene analysis (t cell antigen receptor beta) amplification methodology (HCPCS:81340)
• Gene analysis (tumor protein 53) targeted sequence analysis (HCPCS:81352)
• Test for detecting genes associated with colon cancer, promoter methylation analysis (HCPCS:81288)
• Gene analysis (v-ki-ras2 kirsten rat sarcoma viral oncogene) variants in codons 12 and 13 (HCPCS:81275)
• Gene analysis (kirsten rat sarcoma viral oncogene homolog), additional variants (HCPCS:81276)
• Genetic sequencing localization, initial procedure (HCPCS:88365)
• Genetic sequencing localization, each additional procedure (HCPCS:88364)
• Microsatellite instability analysis (HCPCS:81301)
• Gene analysis (abl proto-oncogene 1, non-receptor tyrosine kinase) (HCPCS:81170)
• Gene analysis (neurotrophic receptor tyrosine kinase 1, 2, and 3) translocation analysis (HCPCS:81194)
• Chromosome analysis for genetic defects, analyze 20-25 cells (HCPCS:88264)
• Gene analysis (v-kit hardy-zuckerman 4 feline sarcoma viral oncogene homolog), targeted sequence (HCPCS:81272)
• Special stained specimen slides to identify organisms including interpretation and report (HCPCS:88312)
• Flow cytometry technique for dna or cell analysis, 9 to 15 markers (HCPCS:88188)
• Flow cytometry technique for dna or cell analysis, 2 to 8 markers (HCPCS:88187)
• Gene analysis (splicing factor [3b] subunit b1) for detection of common variants (HCPCS:81347)
• Gene analysis (fms-related tyrosine kinase 3) internal tandem duplication variants (HCPCS:81245)
• Test for detecting genes associated with blood cancer (HCPCS:81246)
• Translocation analysis (pml-rara regulated adaptor molecule 1) common breakpoint (HCPCS:81315)
• Gene analysis for cancer (neuroblastoma) (HCPCS:81311)
• Test for detecting genes associated with cancer of body organ (HCPCS:81445)
• Gene analysis (isocitrate dehydrogenase 1 [nadp+], soluble) for common variants (HCPCS:81120)
• Gene analysis (isocitrate dehydrogenase 2 [nadp+], mitochondrial) for common variants (HCPCS:81121)
• Blood smear interpretation by physician with written report (HCPCS:85060)
• Translocation analysis (bcr/abl1) other breakpoint (HCPCS:81208)
• Gene analysis (nucleophosmin) exon 12 variants (HCPCS:81310)

The enumeration date for this NPI number is 6/24/2006 and was last updated on 12/17/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: